Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Topicscardiovascular

Phys · cardiovascular

Hypertension

Also known as high blood pressure · raised blood pressure · systemic hypertension · essential hypertension · primary hypertension · secondary hypertension · resistant hypertension · hypertensive emergency · accelerated hypertension · malignant hypertension · isolated systolic hypertension

Consultant-physician-depth guide to hypertension — definition and classification across ANZ/UK/US guidelines, pathophysiology, secondary causes workup, target organ damage, lifestyle and pharmacological management, resistant hypertension, and hypertensive emergencies. Structured for FRACP DWE and DCE preparation.

high8 referencesUpdated 26 July 202619 min readVerification in progress

Practise this topic

  • 8 MCQs
  • SAQ
  • Viva
  • Case

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 1MRCP Part 2MRCP PACESABIM Internal Medicine

Red flags

  • Hypertensive emergency — BP elevation with acute target organ damage (encephalopathy, dissection, pulmonary oedema, eclampsia)
  • New or resistant hypertension under age 40 — investigate for secondary cause
  • Hypokalaemia in a hypertensive patient not on diuretics — screen for primary aldosteronism
  • Episodic hypertension with headache, sweating, palpitations — screen for phaeochromocytoma
  • Radio-femoral delay with upper limb hypertension — coarctation of the aorta
  • Sudden BP rise above baseline with visual disturbance or confusion — hypertensive encephalopathy
On this page
Study tools

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 1MRCP Part 2MRCP PACESABIM Internal Medicine

Red flags

  • Hypertensive emergency — BP elevation with acute target organ damage (encephalopathy, dissection, pulmonary oedema, eclampsia)
  • New or resistant hypertension under age 40 — investigate for secondary cause
  • Hypokalaemia in a hypertensive patient not on diuretics — screen for primary aldosteronism
  • Episodic hypertension with headache, sweating, palpitations — screen for phaeochromocytoma
  • Radio-femoral delay with upper limb hypertension — coarctation of the aorta
  • Sudden BP rise above baseline with visual disturbance or confusion — hypertensive encephalopathy

Hypertension

The one-line answer

Hypertension is the single most important modifiable risk factor for cardiovascular disease worldwide, and at every encounter the registrar's job is threefold: confirm the BP is genuinely elevated (not white-coat), assess for target organ damage, and decide on a target and a plan the patient will actually follow. Four drug classes are first-line — ACE inhibitor, ARB, calcium channel blocker and thiazide — and the preferred combination is an ACE inhibitor or ARB plus a CCB. Resistant hypertension earns spironolactone as the fourth agent. [1]

Meet the patient

A 52-year-old man presents for a routine check. His clinic BP is 158/96 on two readings. He smokes, has a BMI of 31, and his father had a stroke at 65. He asks whether he really needs tablets. [1]

The question is not just whether the number is high — it is whether the number is real (confirm with ABPM or home monitoring), what damage it has already done (ECG, urine ACR, renal function, fundoscopy), and what his cardiovascular risk looks like once you factor in smoking and family history. Confirm before you diagnose; assess damage before you treat. [1]


Physician Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]Wright JT Jr, Williamson JD, Whelton PK, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control N Engl J Med, 2015.PMID 26551272
  2. [2]Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med, 2008.PMID 19052124
  3. [3]Williams B, MacDonald TM, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Lancet, 2015.PMID 26414968
  4. [4]Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension, 2018.PMID 29133354
  5. [5]Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J Hypertens, 2023.PMID 37345492
  6. [6]Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab, 2016.PMID 26934393
  7. [7]ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA, 2002.PMID 12479763
  8. [8]Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis N Engl J Med, 2014.PMID 24245566

Test yourself

Practise what you just read

  • 8 MCQs
  • SAQ
  • Viva
  • Case
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHeart FailurecardiovascularNextInfective Endocarditiscardiovascular